Datavault AI Inc. Forms Strategic Alliance with Scilex Holding Company
Datavault AI Inc. has embarked on an exciting journey with a new $10 million worldwide exclusive license agreement. This collaboration is centered around tokenization and monetization in the biotech and biopharma realms. The agreement enables Scilex Holding Company to utilize Datavault AI's cutting-edge technology to develop a Biotech Exchange platform.
Unlocking New Possibilities in Biotechnology
The partnership is a significant leap in how biotech assets are managed and traded. By incorporating Datavault AI's advanced data platforms, Scilex is set to enhance the secure tokenization and commercialization of various biotech assets, including genomic data, DNA information, diagnostics, and therapeutic offerings. This innovative approach gives rise to new monetization methods and promises to reshape the biotech landscape.
Transformative Potential for the Pharmaceutical Sector
This agreement poses tremendous opportunities, with Datavault AI estimating a stunning potential near $2.0 trillion in tokenized pharmaceutical and diagnostic sales. Such advancements allow companies in the biotech sector to secure non-dilutive funding for R&D, fostering the development and commercialization of vital healthcare products.
Robust Intellectual Property Portfolio
At the heart of this landmark deal is Datavault AI's extensive intellectual property rights, featuring patent applications such as the innovative "Platform and Method for Tokenizing DNA Data." This pivotal technology enables the establishment of a reliable framework for managing and exchanging sensitive genetic information securely. Moreover, a suite of additional issued and pending patents supports the functional capabilities of the Biotech Exchange.
Innovation Through Collaboration
Previously, Datavault AI collaborated with Brookhaven National Laboratory, developing a biofuel research project that showcased their capabilities in AI-driven technologies and high-performance computing for practical applications in bioenergy. This license further extends Datavault AI’s innovative technologies beyond previous collaborations, making strides in the biotechnology field.
Financial Considerations of the Agreement
The agreement comes with defined financial terms. Datavault AI is set to receive a non-refundable upfront licensing fee, dispensed in four equal payments of $2.5 million. These installments are due between 2025 and 2026, along with potential sales milestone payments totaling an impressive $2.55 billion contingent upon Scilex's performance.
About Datavault AI Inc.
Datavault AI Inc. is a trailblazer in the domain of AI-focused data solutions, striving to monetize and tokenize assets efficiently. Positioned within various sectors, their technology suite is adaptable and extensively customizable, featuring AI and machine learning capabilities to reinforce industries like healthcare, fintech, and real estate among others.
About Scilex Holding Company
Scilex Holding Company stands as a forward-thinking entity dedicated to enhancing pain management solutions through non-opioid therapies. Their product offerings include innovative drugs targeting significant areas of health, reflecting their commitment to improving patient outcomes across various conditions.
Frequently Asked Questions
What is the purpose of the license agreement between Datavault AI and Scilex?
The agreement allows Scilex to use Datavault AI's technology to tokenize and monetize biotech assets, creating a Biotech Exchange platform.
How much is the licensing deal worth?
The licensing agreement is valued at $10 million, with payments structured over several installments.
What areas does the licensing technology cover?
The technology focuses on managing genomic data, DNA information, diagnostics, and therapeutic products.
What is the anticipated market opportunity for tokenization mentioned by Datavault AI?
Datavault AI points to a potential market of approximately $2.0 trillion in pharmaceutical drug sales and diagnostics for tokenization opportunities.
What technologies define Datavault AI's offerings?
Datavault AI features a diverse technology suite that emphasizes secure data handling, artificial intelligence applications, and high-performance computing, adaptable across various industries.
